Oncology
5,302 studies557 in 7 days2,546 in 30 days
Filters
Latest
5,302 studies
- Durable biochemical and radiographic response during toripalimab treatment in MSI-high/TMB-high mCRPC: a case report
- Multiple sclerosis relapse following gamma knife radiosurgery for meningioma in a patient treated with natalizumab: case report
- Prognostic value of the inflammatory burden index in predicting 1-year mortality in patients undergoing cardiac resynchronization therapy for heart failure
- Comparison of feasibility, inter-instrument agreement, and prognostic value of four frailty assessment instruments in geriatric colorectal cancer patients: a 3-year multicenter prospective cohort study
- Case Report: Ribociclib-associated bilateral neurotrophic keratitis requiring amniotic membrane transplantation during adjuvant treatment of early breast cancer
- Boundary-aware geometric Mamba network for breast tumor segmentation in 3D MRI
- Baseline SII and SIRI identify immune-inflammatory susceptibility and improve risk stratification of early subclinical cardiac dysfunction during non-steroidal aromatase inhibitor therapy
- Cytarabine-based mobilisation yields higher CD34+ cell counts than cyclophosphamide regardless of prior daratumumab exposure in multiple myeloma
- Barriers and facilitators to symptom-related help-seeking among men with genitourinary malignancies: a qualitative study
- Genesis—progression of early jaw osteoradionecrosis in head and neck cancer survivors: dynamics of independent but interconnected factors
- Population cellular kinetics and exposure-CSR analysis of CAR-T cells in Chinese patients with relapsed/refractory B-ALL
- Pembrolizumab plus lenvatinib in the treatment of unresectable cutaneous angiosarcoma: a study protocol of multicentre, open-label phase II study (NCCH2213, PLAS)
- Chemokine–receptor axes in immune–tumor cell communication: spatial niches, immune exclusion, and therapy resistance
- CAR-T cell therapy for solid tumors: antigen landscape, biological barriers, and engineering strategies for clinical translation
- Autonomous AI research agents in pancreatic ductal adenocarcinoma immunology: from multimodal evidence to experimental validation
- Molecular and immune-mediated resistance to antibody-drug conjugates in breast cancer
- Clinical characteristics of cadonilimab-associated infusion reactions: a severity-stratified analysis of 52 cases and preliminary management framework
- Analytical Performance of the EasyPGX Ready NTRK Fusion Assay for Detecting Tumor-Agnostic NTRK Gene Fusions in Solid Tumors
- Coniferaldehyde Reverses PGK1–3-Phosphoglycerate–L-Serine Metabolic Reprogramming in Hindlimb Ischemia
- Superactivation of p53 Using Drug Combinations and New Insights into p53 Functions and Anticancer Therapy
- The Proliferation–Invasion Dichotomy: Transcriptomic Signatures of lncRNA and Ubiquitin–Proteasome Networks in Hypermutated Endometrial Cancer
- Opposing Natural Killer and Macrophage Associations Are Masked Within a CD16/IL-15/IL-15RA Composite Score in Metastatic Urothelial Carcinoma
- NAD+ analogues for decoding the biological chemistry of PARP-mediated ADP-ribosylation
- Nivolumab in patients with advanced solid tumors with ctDNA-defined high blood tumor mutational burden: a phase II trial.
- An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma.